KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Change in Inventory (2021 - 2025)

Aurinia Pharmaceuticals (AUPH) has disclosed Change in Inventory for 5 consecutive years, with $897000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Inventory rose 74.51% year-over-year to $897000.0, compared with a TTM value of $6.5 million through Dec 2025, up 1454.72%, and an annual FY2025 reading of $6.5 million, up 1454.72% over the prior year.
  • Change in Inventory was $897000.0 for Q4 2025 at Aurinia Pharmaceuticals, up from -$1.7 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $7.0 million in Q1 2023 and bottomed at -$1.7 million in Q3 2025.
  • Average Change in Inventory over 5 years is $1.8 million, with a median of $755500.0 recorded in 2022.
  • Peak annual rise in Change in Inventory hit 12341.07% in 2025, while the deepest fall reached 1130.22% in 2025.
  • Year by year, Change in Inventory stood at $278000.0 in 2021, then soared by 120.86% to $614000.0 in 2022, then surged by 1021.34% to $6.9 million in 2023, then crashed by 92.53% to $514000.0 in 2024, then skyrocketed by 74.51% to $897000.0 in 2025.
  • Business Quant data shows Change in Inventory for AUPH at $897000.0 in Q4 2025, -$1.7 million in Q3 2025, and $308000.0 in Q2 2025.